EN
HI
Cohance Lifesciences Share price
COHANCE
475.9
16.95 (-3.44%)NSE
BSE
Last updated on 9 Jan, 2026 | 15:58 IST
BUYSELL
Today's High
494.70
Today's Low
472.30
52 Week Low
472.30
52 Week High
1328.00
The current prices are delayed, login to your account for live prices
Login Cohance Lifesciences Chart
Cohance Lifesciences Share Key Metrics
Volume
8.56 L
Market Cap
18206.37 CR
LTQ@LTP
10@475.90
ATP
479.76
Var Margin
35 %
Circuit Range
394.3-591.4
Delivery %
83.56 %
Value
41.05 CR
ASM/GSM
No
Market Lot
1
Summary
At 9 Jan, 2026 | 15:58, Cohance Lifesciences share price stands at ₹475.9, showing a 16.95% -3.44 for the day. The stock’s intraday movement has stayed between ₹472.30 and ₹494.70, while on a 52-week basis it has fluctuated from ₹472.30 to ₹1328.00.
In terms of trading activity, Cohance Lifesciences has recorded a volume of 855550 shares, with a market capitalisation of ₹382567140. The stock’s Average Traded Price (ATP) stands at ₹47976, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10,47590. The stock operates within a circuit range of ₹394.3-591.4, with a Value of ₹41.05 CR. The Delivery Percentage for the day is 83.56%. Additionally, Cohance Lifesciences currently falls under the No framework, and trades with a market lot size of 1.
Cohance Lifesciences Fundamentals
View MoreP/E Ratio
73.3
P/B Ratio
4.8
Div. Yield
0
Sector P/E
69.98
Sector P/B
0.95
Sec. Div. Yield
0.57
Cohance Lifesciences Resistance and Support
Pivot 997.07
Resistance
First Resistance
1012.14
Second Resistance
1033.57
Third Resistance
1048.64
Support
First Support
975.64
Second Support
960.57
Third Support
939.14
Cohance Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results |
Cohance Lifesciences News
National Company Law Tribunal clears Casper Pharma’s merger with Suven Pharmaceuticals
Oct 30 2024 05:57:11
Read More
About Cohance Lifesciences
NSE : 17945
BSE : 543064
ISIN : INE03QK01018
Cohance Lifesciences Management
| Name | Position |
|---|---|
| Mr. Vivek Sharma | Executive Chairman |
| Dr. V Prasada Raju | Managing Director |
Cohance Lifesciences Similar Stocks
Pfizer Ltd.
4871.80
65.80 (1.37%)
Eris Lifesciences Ltd.
1508.80
-25.60 (1.67%)
Sai Life Sciences Ltd.
923.30
-35.25 (3.68%)
Onesource Specialty Pharma Ltd.
1760.40
-25.50 (1.43%)
Neuland Laboratories Ltd.
14774.00
-46.00 (0.31%)
Astrazeneca Pharma India Ltd.
8340.00
-78.50 (0.93%)
Poly Medicure Ltd.
1776.30
-0.60 (0.03%)
Jubilant Pharmova Ltd.
1064.30
-10.20 (0.95%)
Natco Pharma Ltd.
890.20
-19.50 (2.14%)
Dr. Agarwal's Health Care Ltd.
504.50
1.10 (0.22%)
Cohance Lifesciences FAQs
The Buying Price of Cohance Lifesciences share is 475.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cohance Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cohance Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cohance Lifesciences shares is 73.3. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cohance Lifesciences shares is 4.8. Useful to assess the stock's value relative to its book value.
To assess Cohance Lifesciences’s valuation compare Sector P/E, P/B which are 69.98 & 0.95 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cohance Lifesciences is 18206.37 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cohance Lifesciences share price is 1328.00 & 472.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cohance Lifesciences belongs to the Healthcare sector.